Martin Hoenigl, ECCMID 2021: Challenges in Treating Invasive Candida Infections
We were delighted to meet with Martin Hoenigl (University of California San Diego & Medical University of Graz, Graz, Austria) to discuss the current challenges in treating invasive candida infections.
The abstract entitled: ‘Outcomes of oral ibrexafungerp in 33 patients with refractory fungal diseases, interim analysis of a phase III open-label study (FURI)’ was presented at the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID).
- Could you give us a brief overview of the current challenges in treating invasive Candida infections? (0:22)
Disclosures: Martin Hoenigl has received research support from Gilead, Astellas, Pfizer, Scynexis, F2G and NIH.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed in coverage of the 31st ECCMID Congress 2021.
Share this Video
Related Videos In Fungal Infections
Kayla Stover Hielscher, IDWeek 2022: Isavuconazole – a good treatment option for Candida species?
Isavuconazole is a once-daily antifungal, used to treat a wide array of fungal infections. In this touchINFECTIOUS DISEASES interview, we met with Prof. Kayla Stover Hielscher (University of Mississippi School of Pharmacy, Jackson, MS, USA) to discuss isavuconazole’s properties and the efficacy and safety compared to other treatment options. The abstract entitled: ‘This Drug for […]
Martin Hoenigl, IDWeek 2022: Candidemia prognosis and unmet needs in its treatment
Candidemia is the one of the most common form of invasive candidiasis, and in some countries the most common causes of bloodstream infections in hospitalized patients. In this touchINFECTIOUS DISEASES interview, we met with Dr Martin Hoenigl (Medical University of Graz, Austria) to discuss the prognosis of candidemia, the unmet needs in its treatment, and […]
Martin Hoenigl, IDWeek 2022: Guideline adherence predicts outcomes of candidemia in Europe
In this touchINFECTIOUS DISEASES interview, we met with Dr Martin Hoenigl (Medical University of Graz, Austria) to discuss ECMM Candida III Multinational European study, which collected data on epidemiology, risk factors, treatment, and outcomes of culture proven candidemia across Europe, to assess how adherence to guideline recommendations correlate with outcomes. The abstract entitled: ‘Guideline Adherence […]
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!